XENLETA
Nabriva Therapeutics US, Inc.
Application Filed: 2019-03-08
Trademark Application Details
Mark For: XENLETA® trademark registration is intended to cover the categories of
The trademark application has been registered with the Office.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88332586 |
| Registration Number | 6043681 |
| Mark Literal Elements | XENLETA |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2020-03-23 |
| Basis | 1(a) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | Yes |
| Intent To Use | No |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Karen K. Won |
| Attorney Docket Number | 331564-TEMP |
| Law Office Assigned | L90 |
| Employee Name | MCDORMAN, ROGER THOMAS |
Timeline
| 2019-03-08 | Application Filed |
| 2019-05-16 | Location: TMEG LAW OFFICE 109 |
| 2019-05-16 | Status: Live/Pending |
| 2019-05-16 | Transaction Date |
| 2019-07-16 | Published |
| 2019-07-16 | Published for Opposition |
| 2019-09-01 | Date of First Use |
| 2019-09-01 | Date of Use In Commerce |
| 2020-03-23 | Location: PUBLICATION AND ISSUE SECTION |
| 2020-04-28 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2020-04-28 | Trademark Registered |
| 2025-04-28 | Maintenance Early File Date |
| 2026-04-28 | Maintenance On Time Date |
| 2026-10-28 | Maintenance Late Fee Date |
Trademark Parties (Applicants & Owners)
| Party: |  Nabriva Therapeutics US, Inc. |
| Address | 1000 Continental Drive, Suite 600 King of Prussia, PENNSYLVANIA UNITED STATES 19406 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Drawing | JPEG | 2019-03-08 |
 TEAS RF New Application | MULTI | 2019-03-08 |
| Offc Action Outgoing | XML | 2019-05-22 |
| XSearch Search Summary | XML | 2019-05-22 |
| Response to Office Action | XML | 2019-05-30 |
| Amendment and Mail Process Complete | MULTI | 2019-06-06 |
| Notation to File | XML | 2019-06-07 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2019-06-08 |
| Publication & Issue Review Complete | MULTI | 2019-06-13 |
| Notice of Publication | XML | 2019-06-26 |
| Notification Of Notice of Publication | XML | 2019-06-26 |
| OG Publication Confirmation | XML | 2019-07-16 |
| Notice of Allowance | XML | 2019-09-10 |
| Change of Address | XML | 2019-10-30 |
| TEAS Rev, App and/or COA of Atty/Dom.Rep | APPLICATION/XML | 2019-10-30 |
| Change Address or Representation Form | XML | 2020-02-19 |
| Specimen | JPEG | 2020-02-19 |
| Statement of Use | MULTI | 2020-02-19 |
| Change Address or Representation Form | XML | 2020-02-20 |
| ITU Unit Action | MULTI | 2020-03-10 |
| Notice of Acceptance of Statement of Use | XML | 2020-03-24 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-03-24 |
| Registration Certificate | 2020-04-28 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for treating respiratory illnesses; antibiotics; pharmaceutical preparations for the treatment of pneumonia and bacterial infections. FIRST USE: 20190900. FIRST USE IN COMMERCE: 20190900
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations; antibiotics; pharmaceutical preparations for the treatment of pneumonia and bacterial infections |
| GS0051 | Pharmaceutical preparations for treating respiratory illnesses; antibiotics; pharmaceutical preparations for the treatment of pneumonia and bacterial infections |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| REGISTERED-PRINCIPAL REGISTER | 2020-04-28 | |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2020-03-24 | |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2020-03-23 | |
| STATEMENT OF USE PROCESSING COMPLETE | 2020-03-08 | 65362 |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2020-03-07 | 65362 |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-02-20 | |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-02-20 | |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-02-20 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-02-20 | |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-02-20 | 88888 |
| USE AMENDMENT FILED | 2020-02-19 | 65362 |
| TEAS STATEMENT OF USE RECEIVED | 2020-02-19 | |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-02-19 | |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-02-19 | |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-02-19 | 88888 |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-10-30 | |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2019-10-30 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-10-30 | |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-09-10 | |
| PUBLISHED FOR OPPOSITION | 2019-07-16 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-07-16 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-06-26 | |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2019-06-12 | 70629 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-06-07 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-06-05 | 70629 |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-06-05 | 70629 |
| ASSIGNED TO LIE | 2019-06-04 | 70629 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-05-30 | |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-05-22 | 6325 |
| NON-FINAL ACTION WRITTEN | 2019-05-22 | 90285 |
| NON-FINAL ACTION E-MAILED | 2019-05-22 | 6325 |
| ASSIGNED TO EXAMINER | 2019-05-16 | 90285 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-03-27 | |
| NEW APPLICATION ENTERED IN TRAM | 2019-03-12 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 XENLETA 88503355 not registered Live/Pending |
Nabriva Therapeutics US, Inc. 2019-07-08 |
 XENLETA 88332586 not registered Live/Pending |
Nabriva Therapeutics US, Inc. 2019-03-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 